CHU de Caen Normandie
Caen, 14000, France
NCT Number: NCT07050953
This study aims to assess the prevalence of ascending aortic dilation in athletes from the general population undergoing routine sports medicine evaluation. It also evaluates the predictive factors and the reproducibility of focused cardiac ultrasound.
Looking for future studies?
Notify Me10 year and older
All sexes
Observational
Caen, 14000, France
Ascending aortic dilation is a potentially serious and underdiagnosed cardiovascular condition, particularly in the context of physical activity. While its prevalence has been studied in elite athletes, little data is available regarding the general athletic population undergoing routine sports medicine evaluation. This study aims to investigate the prevalence of ascending aortic dilation in a general population of recreational and competitive athletes.
This is an observational study conducted at the Sports Medicine Department of Caen University Hospital (France). The study will include athletes over the age of 10 who consult for a pre-participation medical evaluation. A focused cardiac ultrasound (FCU) protocol targeting the ascending aorta will be systematically performed using a portable ultrasound device during routine clinical assessment. When indicated, a standard transthoracic echocardiography (TTE) will be used as the reference method for comparison.
The primary objective of the study is to estimate the prevalence of ascending aortic dilation in this population. The secondary objective is to explore potential predictive factors, including cardiovascular risk factors and exercise history.
This study may help clarify the utility of FCU as a screening tool in sports medicine and contribute to improved early detection of aortic abnormalities in apparently healthy, physically active individuals. Further research may be warranted to assess long-term cardiovascular outcomes in this population.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
A focused cardiac ultrasound will be performed to measure the dimensions of ascending aorta
Time frame: Baseline
Proportion of athletes (recreational and competitive) identified with ascending aortic dilation, as determined by focused cardiac ultrasound. Dilation is defined as an aortic diameter ≥ 40 mm and/or a Z-score ≥ 2, according to age-adjusted reference values.
Time frame: Baseline
Association between ascending aortic dilation and clinical variables, including age, sex, blood pressure, body mass index, cardiovascular risk factors, and characteristics of physical activity
University Hospital, Caen
Other
Acronym: PRAADS
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03718312
Aneurysm, Aortic Aneurysm
Rouen, France
View Trial DetailsNCT01534819
Aneurysm, Aortic Aneurysm
Birmingham, Alabama, United States
View Trial DetailsNCT02784769
Aneurysm, Aortic Aneurysm
Reims, France
View Trial DetailsNCT05711693
Abnormalities, Multiple, Aneurysm
Paris, France
View Trial Details